Literature DB >> 28634213

Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment.

Henry M Olivera-Perez1, Larry Lam1, Johnny Dang1, Weilan Jiang1, Fabian Rodriguez1, Elizabeth Rigali1, Sarah Weitzman1, Verna Porter2, Liudmilla Rubbi1, Marco Morselli1, Matteo Pellegrini1, Milan Fiala3.   

Abstract

Macrophages (Mϕs) of patients with Alzheimer's disease and mild cognitive impairment (MCI) are defective in amyloid-β1-42 (Aβ) phagocytosis and have low resistance to apoptosis by Aβ. Omega-3 fatty acids (ω-3s) in vitro and in vivo and the ω-3 mediator, resolvin D1, in vitro increase Aβ phagocytosis by Mϕs of patients with MCI. We have investigated the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress by Mϕs in a longitudinal study of fish-derived, ω-3-supplemented patients with MCI. Patients in the apolipoprotein E (ApoE)e3/e3 subgroup over time exhibited an increase of protein kinase RNA-like ER kinase (PERK) expression, Aβ phagocytosis, intermediate M1-M2 Mϕ type, and a Mini-Mental State Examination (MMSE) rate of change of +1.8 points per year, whereas patients in the ApoEe3/e4 subgroup showed individually divergent results with an MMSE rate of change of -3.2 points per year. In vitro treatment of Mϕs by fish-derived ω-3 emulsion increased Aβ phagocytosis, PERK expression, and UPR RNA signature, and decreased ER stress signature. Augmented genes in the UPR signature included chaperones, lectins, foldases, and N-linked glycosylation enzymes. In summary, fish-derived ω-3s increase cytoprotective genes and decrease proapoptotic genes, improve immune clearance of Aβ, and are associated with an improved MMSE rate of change in ApoEe3/e3 vs. ApoEe3/e4 patients.-Olivera-Perez, H. M., Lam, L., Dang, J., Jiang, W., Rodriguez, F., Rigali, E., Weitzman, S., Porter, V., Rubbi, L., Morselli, M., Pellegrini, M., Fiala, M. Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment. © FASEB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28634213      PMCID: PMC5602894          DOI: 10.1096/fj.201700290R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  37 in total

1.  Progesterone exerts neuroprotective effects against Aβ-induced neuroinflammation by attenuating ER stress in astrocytes.

Authors:  Yang Hong; Xiaomin Wang; Shuang Sun; Gai Xue; Jianli Li; Yanning Hou
Journal:  Int Immunopharmacol       Date:  2016-02-12       Impact factor: 4.932

Review 2.  Translating endoplasmic reticulum biology into the clinic: a role for ER-targeted natural products?

Authors:  David M Pereira; Patrícia Valentão; Georgina Correia-da-Silva; Natércia Teixeira; Paula B Andrade
Journal:  Nat Prod Rep       Date:  2015-05       Impact factor: 13.423

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy.

Authors:  Justin Zaghi; Ben Goldenson; Mohammed Inayathullah; Albert S Lossinsky; Ava Masoumi; Hripsime Avagyan; Michelle Mahanian; Michael Bernas; Martin Weinand; Mark J Rosenthal; Araceli Espinosa-Jeffrey; Jean de Vellis; David B Teplow; Milan Fiala
Journal:  Acta Neuropathol       Date:  2009-01-13       Impact factor: 17.088

5.  Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress.

Authors:  Rajarshi Ghosh; Likun Wang; Eric S Wang; B Gayani K Perera; Aeid Igbaria; Shuhei Morita; Kris Prado; Maike Thamsen; Deborah Caswell; Hector Macias; Kurt F Weiberth; Micah J Gliedt; Marcel V Alavi; Sanjay B Hari; Arinjay K Mitra; Barun Bhhatarai; Stephan C Schürer; Erik L Snapp; Douglas B Gould; Michael S German; Bradley J Backes; Dustin J Maly; Scott A Oakes; Feroz R Papa
Journal:  Cell       Date:  2014-07-10       Impact factor: 41.582

Review 6.  The mammalian unfolded protein response.

Authors:  Martin Schröder; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

Review 7.  Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.

Authors:  Hussein N Yassine; Meredith N Braskie; Wendy J Mack; Katherine J Castor; Alfred N Fonteh; Lon S Schneider; Michael G Harrington; Helena C Chui
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Authors:  Milan Fiala; Philip T Liu; Araceli Espinosa-Jeffrey; Mark J Rosenthal; George Bernard; John M Ringman; James Sayre; Laura Zhang; Justin Zaghi; Sheila Dejbakhsh; Ben Chiang; James Hui; Michelle Mahanian; Anita Baghaee; Pamela Hong; John Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

Review 10.  The unfolded protein response in neurodegenerative diseases: a neuropathological perspective.

Authors:  Wiep Scheper; Jeroen J M Hoozemans
Journal:  Acta Neuropathol       Date:  2015-07-26       Impact factor: 17.088

View more
  6 in total

Review 1.  Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines.

Authors:  Matthew J Sharman; Giuseppe Verdile; Shanmugam Kirubakaran; Cristina Parenti; Ahilya Singh; Georgina Watt; Tim Karl; Dennis Chang; Chun Guang Li; Gerald Münch
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

Review 2.  Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression.

Authors:  Rita Businaro; David Vauzour; Jerome Sarris; Gerald Münch; Erika Gyengesi; Laura Brogelli; Pedro Zuzarte
Journal:  Front Nutr       Date:  2021-05-14

3.  Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients.

Authors:  Teresa Rubio; Vicente Felipo; Sonia Tarazona; Roberta Pastorelli; Desamparados Escudero-García; Joan Tosca; Amparo Urios; Ana Conesa; Carmina Montoliu
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

4.  Diets with Higher ω-6/ω-3 Ratios Show Differences in Ceramides and Fatty Acid Levels Accompanied by Increased Amyloid-Beta in the Brains of Male APP/PS1 Transgenic Mice.

Authors:  Lara Ordóñez-Gutiérrez; Gemma Fábrias; Josefina Casas; Francisco Wandosell
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

Review 5.  Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?

Authors:  Milan Fiala; Lucas Restrepo; Matteo Pellegrini
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 6.  The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders.

Authors:  Juliette Giacobbe; Bonnie Benoiton; Patricia Zunszain; Carmine M Pariante; Alessandra Borsini
Journal:  Front Psychiatry       Date:  2020-02-28       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.